What will Johnson & Johnson say during their next earnings call?
$17,658 Vol.
Ottava
$634 Vol.
96%
Ottava
$634 Vol.
96%
Rybrevant
$302 Vol.
94%
Rybrevant
$302 Vol.
94%
Carvykti
$75 Vol.
81%
Carvykti
$75 Vol.
81%
Administration
$16,353 Vol.
80%
Administration
$16,353 Vol.
80%
Procedure
$124 Vol.
89%
Procedure
$124 Vol.
89%
Haida Therapeutics
$40 Vol.
73%
Haida Therapeutics
$40 Vol.
73%
Darzalex Faspro
$5 Vol.
75%
Darzalex Faspro
$5 Vol.
75%
China
$5 Vol.
75%
China
$5 Vol.
75%
Europe
$4 Vol.
73%
Europe
$4 Vol.
73%
Nipocalimab / Lupus
$0 Vol.
59%
Nipocalimab / Lupus
$0 Vol.
59%
Trufill
$115 Vol.
43%
Trufill
$115 Vol.
43%
Vaccine
$2 Vol.
37%
Vaccine
$2 Vol.
37%
Regels
This market will resolve based on the next earnings announcement of Johnson & Johnson currently scheduled to take place on January 21, 2026 at 8:30 AM EST.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
Gemaakt op: Jan 12, 2026, 12:39 PM ET
Volume
$17,658Einddatum
Jan 21, 2026Gemaakt op
Jan 12, 2026, 12:39 PM ETResolver
0x65070BE91...What will Johnson & Johnson say during their next earnings call?
$17,658 Vol.
Ottava
$634 Vol.
96%
Rybrevant
$302 Vol.
94%
Carvykti
$75 Vol.
81%
Administration
$16,353 Vol.
80%
Procedure
$124 Vol.
89%
Haida Therapeutics
$40 Vol.
73%
Darzalex Faspro
$5 Vol.
75%
China
$5 Vol.
75%
Europe
$4 Vol.
73%
Nipocalimab / Lupus
$0 Vol.
59%
Trufill
$115 Vol.
43%
Vaccine
$2 Vol.
37%
Over
Volume
$17,658Einddatum
Jan 21, 2026Gemaakt op
Jan 12, 2026, 12:39 PM ETResolver
0x65070BE91...Pas op voor externe links.
Pas op voor externe links.

Pas op voor externe links.
Pas op voor externe links.